Diagnosis of FGFR2-related conditions involves a combination of genetic testing and histological analysis. Genetic tests can identify mutations in the FGFR2 gene, while histological techniques can assess the impact of these mutations on tissue structure and function. For cancer diagnosis, biopsy samples are often analyzed using IHC to detect FGFR2 expression levels and FISH to identify gene amplifications or translocations.
